新光药业 (300519.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(新光药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 70,001,422.2045,664,778.72100,545,259.3054,285,904.0867,075,377.4956,741,838.7992,296,717.31
 营业收入(元) 70,001,422.2045,664,778.72100,545,259.3054,285,904.0867,075,377.4956,741,838.7992,296,717.31
二、营业总成本(元) 56,209,002.5545,485,156.9376,153,559.4952,657,232.2743,871,192.1849,331,077.0857,913,730.09
 营业成本(元) 43,864,990.2233,687,037.6162,812,898.2540,187,831.7839,493,152.9234,028,327.6845,086,023.64
 研发费用(元) 2,662,658.813,009,910.243,945,710.793,371,080.814,089,924.084,091,906.583,581,334.49
 营业税金及附加(元) 1,183,707.81682,926.701,645,256.871,995,042.95684,566.64553,344.061,128,834.10
 销售费用(元) 5,472,917.375,505,789.795,961,742.518,098,941.405,574,860.137,334,380.665,446,085.48
 管理费用(元) 3,482,052.914,565,893.583,676,940.354,828,924.154,379,224.224,749,877.503,960,308.92
 财务费用(元) -457,324.57-1,966,400.99-1,888,989.28-5,824,588.82-10,350,535.81-1,426,759.40-1,288,856.54
  其中:利息收入(元) 460,078.271,970,736.781,892,311.55-10,353,089.521,432,455.961,291,891.86
 资产减值损失(元) -15,582.30179,531.53-377,437.08-19,394.93122,529.99-378,104.28-228,369.99
 信用减值损失(元) -388,445.70-123,746.25121,762.80341,035.04-237,794.53-203,175.99808,077.63
三、其他经营收益
 加:投资收益(元) 1,126,987.381,394,133.791,095,815.46898,442.781,148,289.531,502,054.28523,933.82
 资产处置收益(元) ---67,847.01-303,570.22--12,998.27
 其他收益(元) 435,028.78744,896.95844,197.511,509,810.11506,359.201,153,041.20350,264.42
四、营业利润(元) 14,950,407.812,374,437.8126,008,191.494,054,994.5924,743,569.509,484,576.9235,849,891.37
 加:营业外收入(元) -112,500.00188,474.0023,243.46--8,000.00
 减:营业外支出(元) 1,000,000.00-6,700.004,171.50---
五、利润总额(元) 13,950,407.812,486,937.8126,189,965.494,074,066.5523,743,569.509,484,576.9235,857,891.37
 减:所得税费用(元) 1,675,717.35-190,390.123,359,624.13-1,582,644.723,583,467.121,390,167.395,412,633.90
六、净利润(元) 12,274,690.462,677,327.9322,830,341.365,656,711.2720,160,102.388,094,409.5330,445,257.47
(一)按经营持续性分类
  持续经营净利润(元) 12,274,690.462,677,327.9322,830,341.365,656,711.2720,160,102.388,094,409.5330,445,257.47
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 12,274,690.462,677,327.9322,830,341.365,656,711.2720,160,102.388,094,409.5330,445,257.47
 扣除非经常性损益后的净利润(元) 11,979,179.221,232,508.6721,342,033.394,795,842.0819,593,617.826,065,517.8429,668,599.94
七、每股收益
 一、基本每股收益(元) 0.080.020.140.030.130.050.19
 二、稀释每股收益(元) 0.080.020.140.030.130.050.19
八、其他综合收益(元) 248,007.96175,848.61-407,242.18440,037.4595,258.59200,523.25133,917.02
 归属于母公司股东的其他综合收益(元) 248,007.96175,848.61-407,242.18440,037.4595,258.59200,523.25133,917.02
九、综合收益总额(元) 12,522,698.422,853,176.5422,423,099.186,096,748.7220,255,360.978,294,932.7830,579,174.49
 归属于母公司所有者的综合收益总额(元) 12,522,698.422,853,176.5422,423,099.186,096,748.7220,255,360.978,294,932.7830,579,174.49
公告日期 2024-10-242024-08-272024-04-262024-04-222023-10-252023-08-252023-04-25
审计意见(境内) 标准无保留意见

前瞻产业研究院